- Filter:
- All
- News
- White Papers
- Articles
- Peer-reviewed Work
Atlantis Health's Perspective on Patient Engagement
Wednesday, July 10, 2024
Atlantis Health's definition and measurement of patient engagement in patient support solutions.
Global Oncology Patient Nonadherence Study: An Overview
Thursday, June 27, 2024
Overview of the key findings of Atlantis Health's Global Oncology Patient Nonadherence Study 2024—new insights into why people living with cancer consciously choose not to take their primary self-administered medication as prescribed.
Press release: Global Patient Study Identifies Key Reasons Driving Nonadherence to Self-Administered Cancer Medications
Thursday, June 27, 2024
Atlantis Health announces the key findings of the Global Oncology Patient Nonadherence Study, which provides several new insights including reasons why people living with cancer consciously choose not to take their primary self-administered medication as prescribed.
Evidence for Change: Use of behaviour change techniques in mobile health interventions to enhance treatment adherence and self-management
Thursday, June 6, 2024
A discussion of a recent systematic review of behaviour change techniques in mobile health interventions that promote treatment adherence and self-management in people living with complex long-term health conditions.
Case Study: Improving nurse skills for better patient engagement and outcomes through support programs
Thursday, May 9, 2024
Overview of a nurse training programme in motivational interviewing skills to improve patient engagement and medication adherence.
Evidence for Change: Effectiveness of medication adherence material in patient educational resources on gout
Monday, April 22, 2024
Professor Keith Petrie, our Behavioural Science Lead in the Southern Hemisphere, discusses key findings of his recent content analysis of how medication adherence in addressed in online patient educational resources.
Evidence for Change: Effectiveness of Behaviour Change Techniques in Medication Adherence Interventions
Thursday, April 4, 2024
Professor John Weinman, our Behavioural Science Lead in Europe, discusses his recent systematic review on commonly reported behaviour change techniques in successful medication adherence intervention studies in Type 2 Diabetes.
Case Study: myMeds—A multichannel support programme for Type 2 Diabetes
Tuesday, March 26, 2024
Overview of a highly-personalised, multichannel experience for Type 2 Diabetes patients on oral hypoglycemic agents in a tailored 26-week journey.